Roflumilast Impurity DP 2
Roflumilast Impurity DP 2 (CAS No. 1391052-76-8) is an impurity of Roflumilast. Roflumilast reduces inflammation within the lungs which results in COPD(chronic obstructive pulmonary disease). Roflumilast is employed to forestall the worsening of symptoms in individuals with severe COPD.
Additional information on CAS 1391052-76-8
Roflumilast Related Compound B; 3-(Hydroxy)-N-(3, 5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide
“Sci-Hub, Roflumilast in Symptomatic Chronic Obstructive Pulmonary Disease: Two Randomised Clinical Trials. The Lancet, 374(9691), 685–694, 10.1016/S0140-6736(09)61255-1.” Hkvisa.net, 2022, sci-hub.hkvisa.net/www.sciencedirect.com/science/article/abs/pii/S0140673609612551.
Other products related to roflumilast
|CAS No.||Name of Impurity||Parent Drug||Catalogue No.|